Publications by authors named "Erin Parry"

Claim this Profile
I
Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade.
Reid W Merryman, Justin Kline, Robert A Redd, Harrison Olszewski, Emma Welsh, Erin Michelle Parry

Blood Neoplasia· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An updated understanding of follicular lymphoma transformation.
Erin M Parry, Jessica Okosun

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the Understanding of Richter Transformation.
Philip A Thompson, Erin M Parry

Hematol Oncol Clin North Am· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee.
Christine E Ryan, Inhye E Ahn, Aswin Sekar, Andrew Rawstron, Julia Almeida, Erin M Parry

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Numbat-multiome: inferring copy number variations by combining RNA and chromatin accessibility information from single-cell data.
Ruitong Li, Jean-Baptiste Alberge, Tina Keshavarzian, Junko Tsuji, Johan Gustafsson, Erin Parry

Brief Bioinform· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International consensus statement on diagnosis, evaluation, and research of Richter transformation: the ERIC recommendations.
Adam S Kittai, Monia Marchetti, Othman Al-Sawaf, Ohad Benjamini, Alexey V Danilov, Erin Parry

Blood· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.
James T Yoon, Yinglu Zhou, Mariia Mikhaleva, Daniel S Choi, Stacey M Fernandes, Erin M Parry

Blood Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma.
Andrew Looka, David A Qualls, Daniel Matthews, Robert A Redd, Christopher Sakellis, Erin M Parry

Blood Adv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.
Adam S Kittai, Ying Huang, Sarah Miller, John N Allan, Seema A Bhat, Erin Parry

Blood Cancer J· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.
Adam S Kittai, David Bond, Ying Huang, Seema A Bhat, Emily Blyth, Erin Parry

J Clin Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia.
Paul J Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger

Blood Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular map of CLL and Richter's syndrome.
Amit Sud, Erin M Parry, Catherine J Wu

Semin Hematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
Reid W Merryman, Robert A Redd, Arnold S Freedman, Inhye E Ahn, Jennifer R Brown, Erin M Parry

Ann Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DLBCL arising from indolent lymphomas: How are they different?
Erin M Parry, Sandrine Roulland, Jessica Okosun

Semin Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZNF683 marks a CD8 T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.
Erin M Parry, Camilla K Lemvigh, Stephanie Deng, Nathan Dangle, Neil Ruthen

Cancer Cell· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.
Reid W Merryman, Robert A Redd, Eleanor Taranto, Gulrayz Ahmed, Erin Jeter, Erin M Parry

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Richter syndrome: novel insights into the biology of transformation.
Erin M Parry, Elisa Ten Hacken, Catherine J Wu

Blood· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL.
Nitin Jain, Jayastu Senapati, Beenu Thakral, Alessandra Ferrajoli, Philip Thompson, Erin Parry

Blood Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities.
Elisa Ten Hacken, Tomasz Sewastianik, Shanye Yin, Gabriela Brunsting Hoffmann, Michaela Gruber, Erin M Parry

Blood Cancer Discov· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma.
Reid W Merryman, Laure Michaud, Robert Redd, Patrizia Mondello, Hyesun Park, Erin M Parry

Hemasphere· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome.
Erin M Parry, Ignaty Leshchiner, Romain Guièze, Connor Johnson, Eugen Tausch

Nat Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib.
Noelia Purroy, Yuzhou Evelyn Tong, Camilla K Lemvigh, Nicoletta Cieri, Shuqiang Li, Erin M Parry

Blood· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome.
Matthew S Davids, Kerry A Rogers, Svitlana Tyekucheva, Zixu Wang, Samantha Pazienza, Erin M Parry

Blood· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma.
Reid W Merryman, Robert Redd, Erin Jeter, Jeff L Wong, Kristin McHugh, Erin M Parry

Transplant Cell Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supporting the Next Generation of Scientists to Lead Cancer Immunology Research.
Elise Alspach, Ryan D Chow, Shadmehr Demehri, Jennifer L Guerriero, Shashi Gujar, Erin M Parry

Cancer Immunol Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis